The Automation in Biopharma Industry Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Increased Machine Flexibility and Labour Shortages Driving Industry Growth
Pharmaceutical businesses expressed their desire to use automated solutions more frequently, with 75% stating as much. The primary cause of this, in addition to a labour shortage, is the shift towards injectable and more specialized drugs. Injectable, for instance, have expanded by about 100%, and until 2027, parenteral containers are anticipated to develop at a compound annual growth rate (CAGR) of 5.2%. Pharmaceutical production systems face hurdles from things such as pre-filled syringes and customised doses. So, in order to handle the greater diversity of formats generated in smaller batch sizes, manufacturers are searching for gear that can limit downtime.
Manufacturers were experiencing a shortage of both experienced and unskilled workers; nevertheless, as many producers are aware, conditions have deteriorated significantly in the past two years. In 2022, PMMI, the Packaging and Processing Technologies Association, published a white paper in which it stated that 33% of pharmaceutical businesses were having trouble staffing their operations. Automated technologies and robotics may be able to help pharmaceutical companies with their labour problem. The retirement of almost 80 million baby boomers and the arrival of only 40 million new workers into the labour force at the same time will result in a serious talent deficit over the next 30 years. In the biopharma industry alone, there are over 800,000 workers, but there are over 60,000 unfilled positions, indicating an 8% labour shortage.
What Questions Should You Ask Before Buying a Market Research Report?
- How is the Automation in Biopharma Industry market evolving?
- What is driving and restraining the Automation in Biopharma Industry market?
- How will each point of care diagnostic submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each Automation in Biopharma Industry submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading Automation in Biopharma Industry markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the Automation in Biopharma Industry projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of Automation in
- Biopharma Industry projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the Automation in Biopharma Industry market?
- Where is the Automation in Biopharma Industry market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Automation in Biopharma Industry market today, and over the next 10 years:
- Our 364-page report provides 138 tables, 226 charts, and graphs exclusively to you.
- The report highlights key lucrative areas in the industry so you can target them – NOW.
- It contains in-depth analysis of global, regional and national sales and growth.
- It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Automation in Biopharma Industry market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, our new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), impact of rising Automation in Biopharma Industry prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Technology
- Automation Technology
- Digitization Technology
- Supervisory Control and Data Acquisition (SCADA)
- Distributed Control Systems (DCS)
- Programmable Logic Controllers (PLC)
- Manufacturing Execution System (MES)
- Human-machine Interface (HMI)
- Advanced Process Control (APC)
- Enterprise Resource Planning (ERP)
- Laboratory Information Management System (LIMS)
- Customer Relationship Management (CRM)
- Corrective and Preventive Actions (CAPA)
- Other Automation Technologies
- Internet of things (IoT)
- Artificial Intelligence (AI)
- Digital Twin Technology
- Augmented Reality (AR) and Virtual Reality (VR)
- Predictive Analytics
- Cloud Computing
- Clinical Phase
- Drug Discovery Phase
- Production Phase
- Automation Hardware
- Automation Software
- Services Project Phase
- Services Operation Phase
US $
Euro €
GBP £